139.17MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US60853G1067
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
2.33
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.94
Wall Street Target Price
10.96
EPS Estimate Current Year
-1.15
EPS Estimate Next Year
-0.22
EPS Estimate Current Quarter
-0.33
EPS Estimate Next Quarter
-0.34
Most Recent Quarter
-
Revenue TTM
0
Gross Profit TTM
-36,662,000
EBITDA
-51,890,000
Profit Margin
0.00%
Return On Assets TTM
-28.82%
Return On Equity TTM
-59.01%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
-100.00%
Diluted Eps TTM
-1.94
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
1
Price Sales TTM
156.5613
Price Book MRQ
1.8019
Enterprise Value Revenue
3
Enterprise Value EBITDA
1
321.05
3.56%153.87
3.11%900.00
1.69%158.51
0.32%612.14
0.11%282.85
-2.26%893.52
-0.60%19.06
-0.42%74.14
-0.04%444.93
-0.03%